New molecules that help cells keep proteins healthy
Exploring New Players in Proteostasis
Researchers are looking at whether a natural molecule called polyphosphate and other protein helpers can stop the toxic protein clumps that harm brain cells in Alzheimer's.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11317192 on NIH RePORTER |
What this research studies
This research studies how cells keep proteins in the right shape and how that goes wrong in Alzheimer's disease. The team focuses on polyphosphate, a naturally occurring chain of phosphates, and other chaperone-like factors that can prevent harmful protein aggregation. They use lab experiments with cells, biochemical tests, and model systems to see how these molecules change amyloid formation and protect neurons. The goal is to understand mechanisms that might be targeted later for therapies.
Who could benefit from this research
Good fit: People diagnosed with Alzheimer's disease or mild cognitive impairment, and those interested in research on protein-aggregation mechanisms, would be the most relevant patient group to follow this work.
Not a fit: People seeking an immediate treatment or those without protein-aggregation forms of dementia are unlikely to get direct clinical benefit from this lab-focused project right away.
Why it matters
Potential benefit: If successful, the work could point to new targets or strategies to prevent or reduce the protein clumps that damage brain cells in Alzheimer's, which might lead to future treatments.
How similar studies have performed: Prior laboratory and animal studies have shown that chaperones and polyphosphate can reduce amyloid aggregation and protect cells, but translating those findings into human therapies has not yet been achieved.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Jakob, Ursula H. — University of Michigan at Ann Arbor
- Study coordinator: Jakob, Ursula H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.